Home » ORGANON AND SCHERING CORPORATION TO STOP MALE CONTRACEPTIVE STUDY
ORGANON AND SCHERING CORPORATION TO STOP MALE CONTRACEPTIVE STUDY
Schering AG, Germany and Organon announced that they will continue research in male fertility control separately. Their research collaboration will therefore conclude at the end of the Phase II clinical trial.
BioSpace (http://www.biospace.com/news_story.aspx?StoryID=30369&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct